JENA & ERFURT, Germany & GENEVA--(BUSINESS WIRE)--SIRS-Lab, the innovation leader in molecular diagnostics for life threatening infections announced today that it has successfully raised EURO 10 million new equity capital led by Affentranger Associates alongside with bm-t Beteiligungsmanagement Thüringen and Swiss institutional investors. The company will use the funds to bring new molecular diagnostics to the market to enable fast identification and simple monitoring of sepsis often a deadly disease.
